S. Tezelman et al., PRIMARY HYPERPARATHYROIDISM IN PATIENTS WHO HAVE, RECEIVED RADIATION-THERAPY AND IN PATIENTS WHO HAVE, NOT RECEIVED RADIATION-THERAPY, Journal of the American College of Surgeons, 180(1), 1995, pp. 81-87
BACKGROUND: Primary hyperparathyroidism (HPT) occurs more frequently i
n persons who have been exposed to low-dose therapeutic radiation. Lit
tle information is available concerning whether or not the clinical, m
etabolic, and pathologic manifestations, as well as outcome, differ in
these patients when com pared with patients with sporadic HPT. STUDY
DESIGN: Records from 438 unselected patients with primary HPT, who wer
e treated from 1982 to 1993 were retrospectively analyzed. Ah patients
prospectively received a standard questionnaire preoperatively and po
stoperatively concerning clinical manifestations and a history of radi
ation exposure. Forty-nine patients had a history of radiation exposur
e (rHPT), whereas 389 did not have sporadic HPT (sHPT). RESULTS: There
was no difference in gender (36 women and 13 men versus 289 women and
100 men) or age (mean of 52+/-12 versus 57+/-16 years) in patients wi
th rHPT or sHPT. Fatigue, neuropsychiatric disorders, memory loss, noc
turia, and polyurea were more common in patients with sHPT (p<0.05), w
hereas pain in joints was more common in patients with rHPT (63 versus
52 percent; p<0.001). Serum calcium levels were similar (11.1+/-0.8 v
ersus 11.2+/-0.8 mg per dL), but serum parathyroid hormone levels were
higher in rHPT (448+/-14 percent of upper limit of normal versus 371/-12 percent upper limit of normal). The parathyroid pathology was sim
ilar in the two groups (single adenoma 74 versus 72 percent, hyperplas
ia 14 versus 16 percent, and double adenoma 12 versus 12 percent in rH
PT versus sHPT, respectively), Thyroid pathology was more common in th
e rHPT group (multinodular goiter 27 versus 7 percent and papillary th
yroid carcinoma 14 versus 0.3 percent). Seven (1.8 percent) of patient
s not receiving radiation therapy treated by us had persistent HPT, bu
t no patients receiving or not receiving radiation therapy had recurre
nt HPT during the follow-up period (six years). CONCLUSIONS: Patients
who have HPT after radiation treatment have more thyroid neoplasms but
are otherwise quite similar to other patients with primary hyperparat
hyroidism.